BTB Therapeutics, Inc. — Form D
BTB Therapeutics, Inc. of ESCONDIDO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-02-05. The offering totals $3.3M, of which $3.3M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2025-02-05
- Form: D
- Accession: 0002055053-25-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $3.3M
- Amount sold: $3.3M
- Remaining: $82
- Investors: 10
- Date of first sale: 2025-01-30
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-537472
Issuer
- Name: BTB Therapeutics, Inc.
- CIK: 0002055053
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 26281 WYNDEMERE COURT, ESCONDIDO, CA, 92026
- Phone: (858) 945-3733
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| David Snyder | Director | Philadelphia, PA |
| Masatoshi Hagiwara | Director | Escondido, CA |
| Nobuhiro Yagi | Director | Escondido, CA |
| Takashi Kiyoizumi | Director | Escondido, CA |
| Takashi Kiyoizumi | Executive Officer | Escondido, CA |
Other filings by this issuer (1)
More